In a recent analysis applying systematic screening of lung cancer cases in the Netherlands, PFS was superior in 18 OMD NSCLC patients, the majority with PD‐L1‐high tumors, receiving chemo‐IO compared to a cohort of 50 patients treated with chemotherapy alone.30 This evidence concerns the gene CD274 and non-small cell lung carcinoma.